Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Accretion Nutraveda
|
BDH Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.56 % | 77.09 % | 14.8 % |
|
5yr average Equity Multiplier
|
-1.71 | 7.25 | 1.46 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 1.09 | 0.89 |
|
5yr Avg Net Profit Margin
|
-10.07 % | 14.14 % | 11.59 % |
|
Price to Book
|
0.0 | 0.0 | 3.04 |
|
P/E
|
0.0 | 39.24 | 20.59 |
|
5yr Avg Cash Conversion Cycle
|
-21.7 Days | 88.82 Days | -27.79 Days |
|
Inventory Days
|
80.38 Days | 125.44 Days | 31.79 Days |
|
Days Receivable
|
20.8 Days | 40.1 Days | 116.74 Days |
|
Days Payable
|
154.17 Days | 182.51 Days | 156.43 Days |
|
5yr Average Interest Coverage Ratio
|
-3.16 | 5.76 | 78.47 |
|
5yr Avg ROCE
|
-3.19 % | 50.7 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
-9.3 % | 23.04 % | 14.91 % |
|
5 yr average Debt to Equity
|
-1.91 | 3.41 | 0.1 |
|
5yr CAGR Net Profit
|
n/a | 56.28 % | 7.83 % |
|
5yr Average Return on Assets
|
-6.87 % | 16.23 % | 10.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.54 % | 73.48 % | 49.7 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 8.99 % |
|
Change in Promoter Holding (3 Yrs)
|
47.55 % | 73.48 % | 0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
Accretion Nutraveda
|
BDH Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|